The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
July 18th 2025
Long-term obesity accelerates aging in young adults, increasing risks for cardiovascular diseases and metabolic dysfunction.
Finerenone Approved by FDA for Treatment of Adults With Heart Failure
July 14th 2025Previously indicated to reduce the risk of end-stage kidney disease, cardiovascular death, and hospitalization for heart failure (HF) in chronic kidney disease, finerenone is now approved for patients with HF directly, offering a new treatment option.
Read More
APhA Foundation Drives Innovative Clinical Models at McKesson ideaShare 2025
July 12th 2025Innovative pharmacist-led care models—from tech-enabled Afib screenings and HPV immunizations to Medicare-supported diabetes prevention—demonstrate how pharmacies are redefining their role in team-based clinical care.
Read More
Pharmacies Lead the Way in Vaccine Equity and Access With Scalable, Sustainable Models
July 10th 2025Annie Eisenbeis, PharmD, MBA, showcased how Missouri’s Pharmacy Vaccine Gap Closure Program is transforming pharmacy-based immunization services through scalable workflows, team training, and a redefined role for pharmacy technicians as community health workers.
Read More
Pharmaconutrition in Practice: How Pharmacists Can Lead the Way in Patient Nutrition and Wellness
July 10th 2025Lara Zakaria, PharmD, introduced the topic of pharmaconutrition, urging pharmacists to integrate food, lifestyle, and gut health into patient care through evidence-based, practical interventions.
Read More
FDA Grants Full Approval to mRNA-1273 COVID-19 Vaccine in Children at Increased Risk
Published: July 10th 2025 | Updated: July 10th 2025mRNA-1273, marketed as Spikevax by Moderna, is now fully approved for individuals aged 6 months through 64 years with high-risk features for severe COVID-19.
Read More
Highlights From NLA 2025: Early LDL-C Reduction and Emerging Therapies
July 9th 2025The 2025 National Lipid Association (NLA) Scientific Sessions highlighted a strategic shift toward early, aggressive cardiometabolic intervention, underscoring the vital role of pharmacists in implementing emerging therapies and optimizing cardiovascular risk reduction.
Read More
McKesson ideaShare 2025 Set to Empower Pharmacy Professionals in Nashville
July 9th 2025Packed with CE sessions, interactive learning, expert insights, and a vibrant expo floor, McKesson ideaShare 2025 aims to equip independent pharmacists with the tools and strategies to elevate patient care and drive pharmacy innovation.
Read More
Hospitalized Adults With Community-Acquired Pneumonia Suffer Significant Morbidity Post Discharge
July 4th 2025Six months following discharge from the hospital, adults who battled community-acquired pneumonia were at heightened risk of losing the ability to perform activities and experiencing poor quality of life.
Read More